Zhejiang Anglikang Pharmaceutical Co Ltd Class A Cash Flow Reinvestment Rate
Zhejiang Anglikang Pharmaceutical Co Ltd Class A cash flow reinvestment rate. Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Cash Flow Reinvestment Rate of 0.15x as of September 2025, reinvesting CN¥16.66 Million (capex CN¥16.66 Million ) from operating cash flow of CN¥112.57 Million. Explore cash flow to debt ratio of Zhejiang Anglikang Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Cash flow reinvestment rate of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. Historical reinvestment intensity for Zhejiang Anglikang Pharmaceutical Co Ltd Class A across 12 annual periods. Explore Zhejiang Anglikang Pharmaceutical Co Ltd (002940) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Cash Flow Reinvestment Rate by Year (2014–2025)
Zhejiang Anglikang Pharmaceutical Co Ltd Class A cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Anglikang Pharmaceutical Co Ltd Class A. For the full cash flow conversion analysis, see Zhejiang Anglikang Pharmaceutical Co Ltd (002940) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥108.26 Million | CN¥244.13 Million | CN¥49.94 Million | ▼ -6.1% |
| 2024 | 0.47x | CN¥119.78 Million | CN¥253.60 Million | CN¥94.46 Million | ▼ -22.5% |
| 2023 | 0.61x | CN¥168.87 Million | CN¥276.91 Million | CN¥124.95 Million | ▼ -78.4% |
| 2022 | 2.83x | CN¥522.18 Million | CN¥184.75 Million | CN¥68.82 Million | ▲ +134.0% |
| 2021 | 1.21x | CN¥238.72 Million | CN¥197.65 Million | CN¥87.32 Million | ▲ +19.3% |
| 2020 | 1.01x | CN¥201.10 Million | CN¥198.61 Million | CN¥90.96 Million | ▼ -5.7% |
| 2019 | 1.07x | CN¥229.28 Million | CN¥213.49 Million | CN¥75.58 Million | ▲ +103.2% |
| 2018 | 0.53x | CN¥70.62 Million | CN¥133.61 Million | CN¥68.17 Million | ▲ +78.4% |
| 2017 | 0.30x | CN¥57.40 Million | CN¥193.77 Million | CN¥54.79 Million | ▲ +31.0% |
| 2016 | 0.23x | CN¥32.05 Million | CN¥141.74 Million | CN¥25.81 Million | ▼ -10.7% |
| 2015 | 0.25x | CN¥35.10 Million | CN¥138.59 Million | CN¥35.10 Million | ▼ -73.6% |
| 2014 | 0.96x | CN¥48.48 Million | CN¥50.46 Million | CN¥48.48 Million | — |